ClinicalTrials.gg
CompletedNCT07912021Updated Nov 3, 2026

The Effect of Using Virtual Simulation on Students' Knowledge and Skill Levels Regarding Postpartum Hemorrhage Management

An interventional study of Virtual Simulation and Case Study in Postpartum Hemorrhage, Nursing Education and Virtual Simulation, sponsored by Uludag University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Uludag University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Oct 2025, registered Oct 2026).
Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
126
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 43 studies in Postpartum Hemorrhage with a site in Turkey — 3 open to participants now, 4 under way, none of them phase 3. Postpartum Hemorrhage · Turkey.

Enrollment
19th of 33
126 · median 150
Started
2025
with 5 others
No phase
30 of 43
3 open now
Registered
43rd of 43
by date
Lead sponsor
2 of 43
Uludag University

Among the 43 studies in Postpartum Hemorrhage with a site in Turkey, this one is the 19th largest by enrollment of the 33 interventional ones that give a count, is one of 6 that started in 2025, is one of 30 with no phase, and was the 43rd registered.

Postpartum Hemorrhage

469 studies on the registry are indexed under Postpartum Hemorrhage; 76 are open to participants now.

Browse Postpartum Hemorrhage studies →

Open to participants now

3 of the 43 studies in Postpartum Hemorrhage with a site in Turkey are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 42 Postpartum Hemorrhage studies recruiting now, 21 (50%) set no upper age limit and 21 (50%) stop at 75 or younger; 6 take children under 18; 21 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 43 studies in Postpartum Hemorrhage with a site in Turkey, or all of them as a file.
02

Study summary

The purpose of this study is to find out whether virtual simulation helps nursing students learn how to manage postpartum hemorrhage (heavy bleeding after childbirth). Third-year nursing students taking the Obstetrics and Gynecology Nursing course were randomly assigned to one of three groups: virtual simulation, case study, or control. Students' knowledge was measured with a postpartum hemorrhage knowledge test, and their skills were assessed with a skill evaluation checklist during a hybrid simulation scenario. The results will show whether virtual simulation improves students' knowledge and skills compared with case study and standard education.

Read the detailed description

Background: Postpartum hemorrhage (PPH) remains one of the leading causes of maternal mortality worldwide. Nurses play a critical role in the early recognition and timely management of PPH; however, nursing students have limited opportunities to gain clinical experience in this obstetric emergency. Virtual simulation provides a safe, standardized, and repeatable learning environment that may support the development of knowledge and clinical skills in such high-risk, low-frequency situations.

Objective: This randomized controlled trial aims to evaluate the effect of virtual simulation on nursing students' knowledge and skill levels regarding postpartum hemorrhage management, compared with case-based learning and standard education.

Methods: The study was conducted with third-year nursing students enrolled in the Obstetrics and Gynecology Nursing course at Eskisehir Osmangazi University. Prior to the main study, a pilot study was conducted with 15 fourth-year nursing students who had previously completed the course. These students were outside the study population and were not included in the sample or the analysis.

After written informed consent was obtained and the Student Descriptive Characteristics Form was completed, participants were allocated to three groups using stratified randomization: virtual simulation group, case study group, and control group. All participants received standard theoretical education on postpartum hemorrhage, after which the Postpartum Hemorrhage Knowledge Test was administered as a pretest.

Following the theoretical education, students in the virtual simulation group were given a brief orientation to the platform and completed five virtual simulation scenarios on postpartum hemorrhage management over a one-week period. Students in the case study group worked on written case studies based on the same scenarios and developed nursing care plans in small groups of 8-10 students via the Zoom platform. The control group received no additional intervention beyond standard education.

The knowledge test was administered to all groups one week after the intervention (posttest) and four weeks after the intervention (follow-up). Clinical skills were subsequently assessed using the Skill Evaluation Checklist during a hybrid simulation scenario with standardized patients, conducted in mixed groups. Each simulation session was followed by a structured debriefing, after which the knowledge test was administered for the fourth time. Upon completion of the study, students in the control group were given access to the virtual simulation platform for ethical reasons.

Funding: This study was funded by Eskisehir Osmangazi University Scientific Research Projects Coordination Unit (Project No: TDK-2025-3302).

03

Conditions studied

  • Postpartum Hemorrhage
  • Nursing Education
  • Virtual Simulation

Browse trials for

Keywords

  • Virtual Simulation
  • Simulation Training
  • Nursing Education
  • Postpartum Hemorrhage
  • Hybrid Simulation
  • Case-Based Learning
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being a nursing student at Eskisehir Osmangazi University Faculty of Health Sciences, Department of Nursing
  • Being enrolled in the Obstetrics and Gynecology Nursing course
  • Taking the Obstetrics and Gynecology Nursing course for the first time
  • Having a smartphone with an Android or iOS operating system, or a computer
  • Having no communication problems
  • Volunteering to participate in the study and providing written

Exclusion criteria

Exclusion Criteria:

  • Being a graduate of the nursing assistant or midwifery assistant programs of vocational health high schools

Withdrawal Criteria (after randomization):

  • Not completing the assigned intervention (virtual simulation scenarios or case studies)
  • Not completing, or incompletely completing, the knowledge test at any measurement point
  • Not attending the skill assessment
  • Inability to evaluate the video recording of the skill assessment due to technical reasons (excluded from the skill analysis only)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
126 participants (actual)

Study arms

  • Experimental
    Virtual Simulation Group

    Students received standard theoretical education on postpartum hemorrhage, followed by a brief platform orientation and completion of five virtual simulation scenarios on postpartum hemorrhage management over a one-week period.

    Behavioral: Virtual Simulation

  • Active comparator
    Case Study Group

    Students received standard theoretical education on postpartum hemorrhage, followed by case studies based on the same scenarios used in the virtual simulation group. Students developed nursing care plans in small groups of 8-10 via the Zoom platform.

    Behavioral: Case Study

  • No intervention
    Control Group

    Students received only standard theoretical education on postpartum hemorrhage included in the course curriculum, with no additional intervention. After the study was completed, students were given access to the virtual simulation platform for ethical reasons.

Interventions

  • BehavioralVirtual Simulation

    Following a brief orientation (approximately 15 minutes), students completed virtual simulation scenarios on postpartum hemorrhage management over one week.

  • BehavioralCase Study

    Students worked on written case studies based on the same postpartum hemorrhage scenarios and developed nursing care plans in small groups of 8-10 via the Zoom platform.

06

What researchers measure

Primary outcomes

  1. Postpartum Hemorrhage Knowledge Level

    Students' knowledge of postpartum hemorrhage management was assessed using the Postpartum Hemorrhage Knowledge Test developed by Citak and Duran Aksoy (2023). The test consists of 20 questions; each correct answer is scored as 1 point, and each incorrect or blank answer as 0 points. Total scores range from 0 to 20, with higher scores indicating a higher level of knowledge.

    Time frame: Baseline (after theoretical education), 1 week post-intervention, 4 weeks post-intervention, and immediately after the skill assessment.

  2. Postpartum Hemorrhage Management Skill Level

    Students' skills in postpartum hemorrhage management were assessed during a hybrid simulation scenario with standardized patients using the Postpartum Hemorrhage Management Skill Evaluation Form developed by Mert-Karadas and Terzioglu (2019).Each item is rated on a 5-point scale from 0 (performed none of the activities) to 4 (performed all of the activities), yielding a total score ranging from 0 to 160. Higher scores indicate a higher level of skill. A situation-specific scoring approach was used, and outcome assessors were blinded to group allocation.

    Time frame: 4-5 weeks post-intervention

07

Study locations

1 site
  • Eskisehir Osmangazi University Faculty of Health Sciences
    Eskişehir, Eskişehir 26040, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared, as the informed consent obtained from participants did not include permission for data sharing with third parties and in order to protect participant confidentiality. The study findings will be disseminated in aggregate form through the doctoral thesis and peer-reviewed publications.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2025 to primary completion in Dec 2025, 1 month.

Of 112 non-industry interventional studies with no phase under Postpartum Hemorrhage, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 26. This study's 1 month is below that.

Counting every sponsor, half of 119 studies reached it within 16 months; a quarter within 7 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 27, 2026
First posted
Nov 3, 2026
StartActual
Oct 22, 2025
Primary completionActual
Dec 12, 2025
CompletionActual
Dec 12, 2025
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07912021
Lead sponsor
Uludag University
Responsible party
Meryem Unulu (Lecturer, Uludag University) — Principal investigator
First posted
Nov 3, 2026
Start date
Oct 22, 2025
Primary completion
Dec 12, 2025
Completion
Dec 12, 2025
Last update
Nov 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion